In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org medical adviser, discusses some of the research that was published in October 2014.
Listen to the podcast to hear Dr. Wojciechowski explain:

results of a study that found the targeted therapy Herceptin offers long-lasting benefits for women diagnosed with early-stage HER2-positive disease

a study that found occult cancers in more than 2% of women who were having their ovaries removed preventively because of genetics or family history

why Hispanic women still need to take steps to reduce their risk of breast cancer, even if they have a genetic variant that may lower their risk

why more research is needed before a new genomic test can be used to make treatment decisions